Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsElores

    Elores

    Jump to

    • Venus Remedies up 7% on nod from Myanmar to launch Elores

      Venus Remedies has already received patents for Elores from 46 countries. The drug was launched in India in January 2013.

    • Venus inks outlicensing deal for Elores with SA co

      The company, which has inked a memorandum of understanding (MoU) with Austell Laboratories, expects to launch the drug in South Africa by mid-2015.

    • Expect $100m revenue via Elores by FY18: Venus Remedies

      In an interview to CNBC-TV18, Dheeraj Aggarwal, CFO, Venus Remedies spoke about revenue prospects of Elores, for which the company recently won patent from Japan.

    • Venus Remedies shares gain on Japanese patent for Elores

      Venus Remedies received patent from Japanese Patent Office for Elores - the antibiotic against superbugs.

    • Venus Remedies signs deal with Goodwills Co

      Pharma firm Venus Remedies today said it has signed a deal with South Korean drug company Goodwills Co Ltd for exclusive marketing of its antibiotic drug 'Elores'.

    • Venus eyes $100m from new drug 'Elores' in 5 years

      Venus Remedies today said it is aiming to garner around USD 100 million (over Rs 500 crore) in the next five years from its new drug that is used for combating spread of bacterial resistance.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347